and ‡German pre-eclampsia self-help group (Arbeitsgemeinschaft Gestose-Frauen e.V.), Geldener Strasse 45, 47661 Issum, Germany A B S T R A C T HDP (hypertensive diseases in pregnancy) are one of the leading causes of maternal and fetal mortality and morbidity. BMI (body mass index) is an established risk factor for pre-eclampsia, but its role in HELLP syndrome is unknown. We therefore investigated BMI as a risk factor in the development of HELLP syndrome. At the beginning of pregnancy, BMI was measured in 1067 women with a history of HDP and 1063 controls. Diagnoses of HDP were classified according to ISSHP (International Society for the Study of Hypertension in Pregnancy) and BMI according to WHO (World Health Organization) criteria. After verification of exclusion criteria and matching for confounders, 687 women with hypertensive diseases in pregnancy and 601 controls remained for statistical evaluation by χ 2 test and multiple logistic regressions. As a continuous variable, the increase in BMI was associated with an increase in the development of gestational hypertension {OR (odds ratio), 1.1 [95 % CI (confidence interval) 1.062-1.197]} and pre-eclampsia [OR, 1.1 (95 % CI, 1.055-1.144)]}, but not for HELLP syndrome. According to WHO definitions, overweight women (BMI 25 and < 30 kg/m 2 ) had a 2-fold (95 % CI, 1.365-2.983) risk and obese women (BMI 30 kg/m 2 ) had a 3.2-fold (95 % CI, 1.7-5.909) risk of developing pre-eclampsia when compared with women of normal weight (BMI 15.5 and < 25 kg/m 2 ). Being overweight or having obesity had no effect on the risk of HELLP syndrome. As an increased BMI is correlated with the risk of developing pre-eclampsia but not HELLP syndrome, both diseases have a different risk profile. This finding supports that underlying physiological mechanisms in pre-eclampsia vary from those in HELLP syndrome.
INTRODUCTION
The prevalence of obesity is increasing worldwide and across all age groups [1, 2] . In Germany, the prevalence of obesity [BMI (body mass index) 30 kg/m 2 ] in women is between 21.1 and 24.5 %, and more than half of all women are overweight (BMI 25 and < 30 kg/m 2 ) [3] . Being overweight has been associated with an increased rate of obstetric complications and poor neonatal outcomes. Women with a BMI 25 kg/m 2 suffer significantly more often from gestational diabetes [4] [5] [6] . Their children are more often macrosomic [4, 6] , but other studies also report higher incidences of fetal growth restriction [7] . Being overweight is correlated with a dose-dependent increase in the risks of stillbirth and very preterm birth (< 32 weeks) [4, 5] . Overweight women have an augmented risk of delivery by Caesarean section [4] [5] [6] , post-operative morbidity [7] and treatment of their children in a neonatal intensive care unit [4] . When the mother's BMI is > 30 kg/m 2 , the risk of fetal malformation increases from 4-7 % to 11.1 % [8] .
Being overweight and having obesity are also associated with an increased risk of HDP (hypertensive diseases in pregnancy) [4, 6] . HDP are one of the main reasons for maternal death in the U.S.A. and Europe [9, 10] . These diseases are responsible for approx. 15-20 % of premature deliveries and perinatal death [11] . HELLP (HELLP syndrome) is often interpreted as a severe form of PE (pre-eclampsia) [12, 13] , and it is correlated with an increased risk of maternal and fetal morbidity and mortality [14] . Despite intensive research and promising results, an integrated aetiological model of HDP has not been formulated. Termination of pregnancy is the only causal treatment available for HDP. Therefore the prediction of risk or identification of subclinical disease is desirable to identify patients who require increased observation. Currently, patients at risk are difficult to recognize. Increased body weight is one of the earliest known risk factors for HPD; however, its role in HELLP remains unknown. Such a comparison may help to understand the underlying pathophysiological mechanisms, and knowledge of these mechanisms may offer new opportunities for a causal treatment of these diseases. Furthermore, weight reduction seems to be a potential prophylactic option to reduce the risk of PE, in contrast with most of the other known risk factors [15] . The correlation between pre-pregnancy BMI and the risk for PE and HELLP is also of particular interest, as emerging data suggest associations between the influence of maternal and fetal factors during intrauterine growth and the risk of developing adult obesity and its comorbidities [16] . Therefore the aim of our present study was to investigate the role of prepregnancy BMI in PE and HELLP.
MATERIALS AND METHODS
The Hy-Di-Preg study (Hypertensive Disorders in Pregnancy) is a nationwide research project initiated to investigate the role of epidemiological, psychosocial, psychosomatic and genetic factors in the aetiology and course of HDP. The project was designed in cooperation with the German pre-eclampsia self-help group (Arbeitsgemeinschaft Gestose-Frauen e.V.).
From the current literature and the clinical experience of the authors, a standardized questionnaire focused on the objectives of the study was developed. In addition, medical records of each patient were reviewed for relevant data. Questionnaires were sent to 2600 women who asked the German Pre-Eclampsia Society for information on HDP. Of the 2600 women contacted, 168 respondents were professionals, such as physicians, nurses or midwives. We received completed questionnaires from 1067 women who had had at least one episode of HDP. Women also contacted the pre-eclampsia self-help group when hypertensive disease was suspected, but could be excluded by medical evaluation. Therefore the exact response rate of women who had actually had HDP could not be calculated. As gestational diabetes mellitus and obesity seem to be dependent risk factors for pregnancy-induced hypertensive disorders [17] , women with diabetes were excluded from the study.
The control group was recruited from seven hospitals in mid-west Germany. Women were excluded if they presented with HDP, CH (chronic hypertension), a BP (blood pressure) 140/90 mmHg more than once during pregnancy, hypo-or hyper-thyroidism, gestational diabetes, diabetes mellitus, autoimmune diseases and/or proteinuria 0.3 g/l in a 24-h urine sample or 1g/l in a spontaneous urine sample (≈ 1+ on urine dipstick) during pregnancy based upon medical record review. After exclusion, 1484 control women were included in the study. The questionnaire was then handed out and 1233 women agreed to participate. Lack of time was the main reason (92 %) for not participating in the study. We received 1063 completed questionnaires of which 162 were excluded due to incomplete data sets. No statistically significant differences existed between the women participating or refusing to participate/being excluded from the control group because of age, parity or socio-economic status.
All participants provided written informed consent. The study was approved by our Institution's Ethics Committee.
Patients and controls were only included when the complete data set on main outcomes and potential confounders were available. The index pregnancy was defined as the first pregnancy conducted beyond the 24th week of gestation. In the cases, the first pregnancy conducted beyond the 24th week of gestation and complicated by HDP was considered for evaluation. Patients were matched against controls for age, parity, educational level and nationality. We decided on population-matching instead of a pair-matching for two reasons: (i) a pair-matching would have severely limited the number of patients for evaluation; and (ii) the aim of matching was to achieve groups with equal or similar distributions of the matching parameters (and not to perform a paired analysis). Therefore populationmatching is the better method for this situation. To compare the role of BMI in the different types of HDP, we first compared each subgroup of HDP with the same control group.
Definition criteria of HDP
All diagnoses of HDP were confirmed by medical records and classified according to the criteria defined by the ISSHP (International Society for the Study of Hypertension in Pregnancy) [18] as follows: (i) CH, BP 140/ 90 mmHg before 20 weeks of gestation and after 6 weeks postpartum on two occasions 6 h apart; (ii) GH (gestational hypertension), BP 140/90 mmHg after 20 weeks of gestation and no longer than 6 weeks postpartum on two occasions 6 h apart; (iii) PE, GH/CH + proteinuria ( 0.3 g/l in a 24-h urine specimen or dipstick proteinuria score 1+ in a random urine collection); and (iv) HELLP, haemolysis (lactic dehydrogenase 600 units/l), elevated liver enzymes (aspartate aminotransferase 70 units/l and alanine aminotransferase 90 units/l) and platelet count 100 g/l.
Diagnoses were based on measurements of BP, proteinuria, lactic dehydrogenase, aspartate aminotransferase, alanine aminotransferase and platelet count. To exclude any inconsistencies due to varying hospital criteria, the same diagnostic criteria were applied to all study participants. After reviewing the patients medical records for HDP, 687 pregnancies complicated by GH, PE or HELLP and 601 control pregnancies were included in the study.
Confounders

Age
Age was defined as age at the delivery of each pregnancy.
Educational level
To evaluate educational level, we differentiated between primary school, extended primary school, high school and secondary school.
BMI
BMI was calculated as weight per height squared (kg/m 2 ). To evaluate BMI at the beginning of pregnancy, maternal weight from 4 weeks before until the end of the 10th week of gestation was used. According to WHO (World Health Organization) criteria [19] , women were diagnosed as underweight with a BMI < 18.5 kg/m 2 , normal weight with a BMI 18.5 and < 25 kg/m 2 , moderately obese with a BMI 25 and < 30 kg/m 2 , and very obese with a BMI 30 kg/m 2 . Height and weight were evaluated from the questionnaire and confirmed by medical records.
The effect of BMI was controlled for age, parity, ethnic background, educational level, smoking status during pregnancy, multiple pregnancies and family risk factors in first-or second-degree relatives (hypertension, heart disease, stroke, diabetes mellitus, increase of blood lipids and HDP).
Statistical analysis
Student's t test was used to compare group differences in continuous variables. Differences between proportions were analysed using the χ 2 test. Logistic regression models assessed the association between HDP and BMI after adjusting for confounding variables. We used a 
RESULTS
Of 687 women in the study group, 78 (11.4 %) had GH, 286 (41.6 %) PE and 323 (47 %) HELLP. Of the 323 pregnancies with HELLP, 179 (55.4 %) were complicated by haemolysis in combination with hypertonia and proteinuria. Table 1 shows the sociodemographic data of patients and controls. Owing to matching, no statistically significant differences for age, parity, educational level and nationality between women developing GH, PE and/or HELLP compared with control women were seen. Marital status was also similar in both groups; however, the study patients worked more often as leading employees, whereas the percentage of working women and trainees was higher in the control group. Table 2 shows the BMI at the beginning of pregnancy in women developing different types of HDP and the control women. When compared with the controls, women presenting with GH or PE were significantly more overweight or obese at the beginning of their pregnancy. In contrast, BMI at the beginning of the pregnancy showed no association with the development of HELLP. When BMI was investigated as a continuous variable, a statistically significant difference for GH and PE, but not for HELLP, was observed (Table 3) . (Table 4) . Neither overweight nor obese women had an increased risk of HELLP (Table 4) . Being underweight at the beginning of pregnancy did not reduce the risk of PE or HELLP.
Smoking during pregnancy [P < 0.005; OR (odd ratio), 0.55] and the presence of family risk factors as defined above (P < 0.0001; OR, 2.0) had an effect independent of BMI on the risk of HDP.
DISCUSSION
Recent studies have confirmed the long-suspected association between pre-pregnancy weight and HDP, with estimates of the relative risk ranging from 1.57 to 5.19 [20] [21] [22] , depending on the definition of overweight and obesity used. Only two reports show opposite outcomes [23, 24] . In accordance with other studies [6, 12, 13, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , being overweight and having obesity were significant risk factors for developing PE in our present study. However, our data show that increased BMI at the beginning of pregnancy is a risk factor for GH and PE, but not for HELLP. A comparison of adjusted ORs in different studies is hampered by different BMI categories used to distinguish normal weight from underweight, overweight and obesity, as well as a variety of confounders investigated by multiple logistic regressions. Nevertheless, our adjusted ORs for PE in overweight and obese women are well within the range reported by others [6, 12, 20, 21, 23, 29] . In contrast, we could not confirm other results that found a reduced risk of developing PE in underweight women [24, 26] . However, the number of underweight women in our group was small (n = 47), thus this correlation has to be interpreted with caution.
To our knowledge, only three studies have investigated the role of body weight as a risk factor for developing HELLP: two of these [12, 13] investigated HELLP within a category of severe PE; therefore, the differences regarding the role of BMI as a risk factor between different types of HDP could not be analysed separately. The only study differentiating between HELLP and other types of HDP recorded patient weight at admission for delivery [31] . By then BMI will have been influenced by the symptoms of HDP, especially oedema, therefore making it difficult to distinguish between an increased BMI as a cause or a symptom. In addition, weight at admission for delivery varies with gestational age. Furthermore, none of the studies compared the risk of GH, PE and HELLP for the different BMI categories. As reported by Odegard et al. [28] and Moore and Redman [32] , the increase in risk caused by augmented pre-pregnancy weight was confined to mild and moderate PE, but was not present for severe disease. Martin et al. [31] found no significant associations between maternal weight and parameters of HELLP severity. Similar to those results, our present data show that BMI correlates with the risk of GH and PE, but not of HELLP. The difference in the risk profile emphasizes the hypothesis that PE and HELLP develop on the background of variable underlying pathophysiological mechanisms.
Essential hypertension is significantly correlated with weight (P < 0.001), and severe obesity is thought to be associated with PE primarily because of the confounding presence of essential hypertension [31, 33] . However, this mechanism is not relevant to HELLP. Elevated BMI might contribute to HDP through other mechanisms. PE develops in two phases, the first of which is characterized by abnormal placentation with reduced placental blood supply. In the second phase, which is probably caused by oxidative stress, systemic maternal disease occurs [34] . Obesity is associated with dyslipidaemia, such as an increase in plasma/serum triacylglycerols (triglycerides), VLDLs (very-low-density lipoproteins) and small-dense low-density particles, which lead to oxidative stress and to endothelial cell dysfunction, a central pathophysiological feature of PE [22, 34, 35] . Other mechanisms, such as lipid alterations, which influence the synthesis of the vasoactive components thromboxane and prostacyclins [36] , activation of the sympathetic nervous system [37, 38] , and sleep apnoea, which occurs more often in obese than in normal weight women [39] , have also been discussed as risk factors for PE resulting from an increased BMI. Increased cardiac output and oxygen consumption in overweight/obese women may also add to the risk of PE [13] . Apparently, potential mechanisms for transmitting the correlation between BMI and the risk for GH and PE cannot explain why BMI does not act on the risk of HELLP.
Our patients and controls were matched for age, parity, educational level and nationality, so the effect of BMI on the risk of the different HDP is independent of these potential confounders [4, 6, 31, 40] . Since women with diabetes mellitus or gestational diabetes were not included in the patient or control groups, the effect of BMI cannot be explained by an increased number of women suffering from diabetes, a known risk factor for HDP [17] . However, generalization of the results from this study may be limited by its retrospective design.
Despite matching for age and educational level according to high school level, the study patients had significantly more cases in leading employees, whereas in the control group a higher percentage of workers and trainees was found. As an increased BMI is associated with a lower social status [41] , this background supports that BMI is a risk factor for PE. Selection bias resulting from the difference in both groups cannot be excluded.
To our knowledge, this is the only study that gives any information on the role of BMI at the beginning of pregnancy in the development of HELLP. It is also the only one to compare the significance of BMI in the development of GH, PE and HELLP. Weight was based on BMI, which is a better overall measure of obesity than weight alone [40] , and BMI categories represented normal weight, overweight and obesity according to WHO criteria.
Another strength is the high number of GH, PE and HELLP cases, all of which have been meticulously confirmed by reviewing the medical records of each patient. The ethnic background of our study group is very homogenous and medical records were used to confirm the data. Furthermore, the effect of BMI was controlled for possible confounding factors. As our patients and controls were matched for several factors known for their effect on BMI, the logistic regression model was less complex and therefore more valid.
Although weight reduction might decrease the risk of GH and PE [40, 42] , such an effect cannot be expected for HELLP according to our results. Research focusing on prophylactic options influencing the risk of HELLP is urgently needed. As a first step to improve clinical management, differences in the risk profile of both diseases might help to understand the underlying pathophysiological mechanisms. Our findings support the hypothesis that PE and HELLP have different underlying pathological mechanisms. Future research will have to ascertain further differences in risk profile, clinical manifestations and therapeutic options of both diseases, which could possibly determine whether HELLP is indeed a severe form of PE or a (partly) independent entity.
